Lifecore Biomedical (LFCR) Short Interest Ratio & Short Volume → Trump’s last act as President (From Porter & Company) (Ad) Free LFCR Stock Alerts $6.42 -0.04 (-0.62%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lifecore Biomedical Short Interest DataCurrent Short Volume1,890,000 sharesPrevious Short Volume1,790,000 sharesChange Vs. Previous Month+5.59%Dollar Volume Sold Short$11.81 millionShort Interest Ratio / Days to Cover9.5Last Record DateApril 15, 2024Outstanding Shares30,320,000 sharesFloat Size30,000,000 sharesShort Percent of Float6.30%Today's Trading Volume122,165 sharesAverage Trading Volume190,513 sharesToday's Volume Vs. Average64% Short Selling Lifecore Biomedical ? Sign up to receive the latest short interest report for Lifecore Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLFCR Short Interest Over TimeLFCR Days to Cover Over TimeLFCR Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Lifecore Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,890,000 shares $11.81 million +5.6%6.3%9.5 $6.25 3/31/20241,790,000 shares $9.50 million +1.7%6.0%8.7 $5.31 3/15/20241,760,000 shares $12.99 million +1.7%5.9%9.4 $7.38 2/29/20241,730,000 shares $14.45 million +0.6%5.9%12.8 $8.35 2/15/20241,720,000 shares $14.12 million +6.2%5.9%12 $8.21 1/31/20241,620,000 shares $10.58 million -2.4%5.5%11.4 $6.53 Get the Latest News and Ratings for LFCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,660,000 shares $11.40 million +7.8%5.6%11.4 $6.87 12/31/20231,540,000 shares $9.53 million -9.4%5.2%9.7 $6.19 12/15/20231,700,000 shares $9.95 million +4.3%5.7%10.4 $5.85 11/30/20231,630,000 shares $11.69 million -11.9%5.5%9.8 $7.17 11/15/20231,850,000 shares $14.25 million +2.8%6.2%9.8 $7.70 10/31/20231,800,000 shares $12.64 million -5.8%6.1%8.1 $7.02 10/15/20231,910,000 shares $13.58 million +6.7%6.4%8.1 $7.11 9/30/20231,790,000 shares $13.51 million -11.0%6.0%7 $7.55 9/15/20232,010,000 shares $16.18 million +11.7%6.8%7.5 $8.05 8/31/20231,800,000 shares $14.40 million +6.5%6.1%4.9 $8.00 8/15/20231,690,000 shares $16.19 million +0.6%5.7%2.6 $9.58 7/31/20231,680,000 shares $17.57 million +0.6%5.7%2.6 $10.46 7/15/20231,670,000 shares $16.47 million +3.1%5.6%2.7 $9.86 6/30/20231,620,000 shares $15.67 million -36.0%5.5%2.6 $9.67 6/15/20232,530,000 shares $21.63 million +4.6%8.5%3.9 $8.55 5/31/20232,420,000 shares $19.82 million +51.3%8.2%2 $8.19 5/15/20231,600,000 shares $6.85 million No Change5.4%1.4 $4.28 LFCR Short Interest - Frequently Asked Questions What is Lifecore Biomedical's current short interest? Short interest is the volume of Lifecore Biomedical shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,890,000 shares of LFCR short. 6.30% of Lifecore Biomedical's shares are currently sold short. Learn More on Lifecore Biomedical's current short interest. What is a good short interest ratio for Lifecore Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LFCR shares currently have a short interest ratio of 10.0. Learn More on Lifecore Biomedical's short interest ratio. Which institutional investors are shorting Lifecore Biomedical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lifecore Biomedical: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Lifecore Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.30% of Lifecore Biomedical's floating shares are currently sold short. Is Lifecore Biomedical's short interest increasing or decreasing? Lifecore Biomedical saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,890,000 shares, an increase of 5.6% from the previous total of 1,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lifecore Biomedical's float size? Lifecore Biomedical currently has issued a total of 30,320,000 shares. Some of Lifecore Biomedical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lifecore Biomedical currently has a public float of 30,000,000 shares. How does Lifecore Biomedical's short interest compare to its competitors? 6.30% of Lifecore Biomedical's shares are currently sold short. Here is how the short interest of companies compare to Lifecore Biomedical: Trevi Therapeutics, Inc. (1.30%), Zevra Therapeutics, Inc. (5.93%), Rigel Pharmaceuticals, Inc. (2.95%), Organigram Holdings Inc. (5.44%), Alimera Sciences, Inc. (0.21%), Atossa Therapeutics, Inc. (9.86%), Veru Inc. (7.55%), Design Therapeutics, Inc. (7.24%), Galectin Therapeutics Inc. (6.47%), Omeros Co. (23.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Lifecore Biomedical stock? Short selling LFCR is an investing strategy that aims to generate trading profit from Lifecore Biomedical as its price is falling. LFCR shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lifecore Biomedical? A short squeeze for Lifecore Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LFCR, which in turn drives the price of the stock up even further. How often is Lifecore Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LFCR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TRVI Short Interest ZVRA Short Interest RIGL Short Interest OGI Short Interest ALIM Short Interest ATOS Short Interest VERU Short Interest DSGN Short Interest GALT Short Interest OMER Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LFCR) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRevolutionizing Healthcare: A Biotech Stock You Can't IgnoreBehind the Markets